General aspects of the genetics of SLE

References

• Deapen D, Escalante A, Weinrib L, et al. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum 1992; 35: 311–318
   PubMed Web of Science ®Google Scholar
• Hochberg MC. The application of genetic epidemiology to systemic lupus erythematosus. J Rheumatol 1987; 14: 867–869
   PubMed Web of Science ®Google Scholar
• Johnson AE, Gordon C, Palmer RG, Bacon PA. The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth. Arthritis Rheum 1995; 38: 551–558
   PubMed Web of Science ®Google Scholar
• McCarty DJ, Manzi S, Medsger TA, Jr., Ramsey-Goldman R, LaPorte RE, Kwoh CK. Incidence of systemic lupus erythematosus. Race and gender differences. Arthritis Rheum 1995; 38: 1260–1270
   PubMed Web of Science ®Google Scholar
• Lander ES, Schork NJ. Genetic dissection of complex traits. Science 1994; 265: 2037–2048
   PubMed Web of Science ®Google Scholar
• Laird NM, Lange C. Family-based designs in the age of large-scale gene-association studies. Nat Rev Genet 2006; 7: 385–394
   PubMed Web of Science ®Google Scholar
• Carlson CS, Eberle MA, Kruglyak L, Nickerson DA. Mapping complex disease loci in whole-genome association studies. Nature 2004; 429: 446–452
   PubMed Web of Science ®Google Scholar
• Craig DW, Stephan DA. Applications of whole-genome high-density SNP genotyping. Expert Rev Mol Diagn 2005; 5: 159–170
   PubMed Web of Science ®Google Scholar
• Theofilopoulos AN, Dixon FJ. Murine models of systemic lupus erythematosus. Adv Immunol 1985; 37: 269–390
   PubMed Web of Science ®Google Scholar
• Rigby RJ, Fernando MM, Vyse TJ. Mice, humans and haplotypes—the hunt for disease genes in SLE. Rheumatology (Oxford) 2006; 45: 1062–1067
   Google Scholar
• Cantor RM, Yuan J, Napier S, et al. Systemic lupus erythematosus genome scan: Support for linkage at 1q23, 2q33, 16q12–13, and 17q21–23 and novel evidence at 3p24, 10q23–24, 13q32, and 18q22–23. Arthritis Rheum 2004; 50: 3203–3210
   PubMed Web of Science ®Google Scholar
• Gaffney PM, Kearns GM, Shark KB, et al. A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families. Proc Natl Acad Sci USA 1998; 95: 14875–14879
   PubMed Web of Science ®Google Scholar
• Gaffney PM, Ortmann WA, Selby SA, et al. Genome screening in human systemic lupus erythematosus: Results from a second Minnesota cohort and combined analyses of 187 sib-pair families. Am J Hum Genet 2000; 66: 547–556
   PubMed Web of Science ®Google Scholar
• Gray-McGuire C, Moser KL, Gaffney PM, et al. Genome scan of human systemic lupus erythematosus by regression modeling: Evidence of linkage and epistasis at 4p16–15.2. Am J Hum Genet 2000; 67: 1460–1469
   PubMed Web of Science ®Google Scholar
• Johansson CM, Zunec R, Garcia MA, et al. Chromosome 17p12–q11 harbors susceptibility loci for systemic lupus erythematosus. Hum Genet 2004; 115: 230–238
   PubMedGoogle Scholar
• Koskenmies S, Lahermo P, Julkunen H, Ollikainen V, Kere J, Widen E. Linkage mapping of systemic lupus erythematosus (SLE) in finnish families multiply affected by SLE. J Med Genet 2004; 41: e2–e5
   Google Scholar
• Lindqvist AK, Steinsson K, Johanneson B, et al. A susceptibility locus for human systemic lupus erythematosus (hSLE1) on chromosome 2q. J Autoimmun 2000; 14: 169–178
   PubMedGoogle Scholar
• Moser KL, Neas BR, Salmon JE, et al. Genome scan of human systemic lupus erythematosus: Evidence for linkage on chromosome 1q in African–American pedigrees. Proc Natl Acad Sci USA 1998; 95: 14869–14874
   PubMed Web of Science ®Google Scholar
• Nath SK, Quintero-Del-Rio AI, Kilpatrick J, Feo L, Ballesteros M, Harley JB. Linkage at 12q24 with systemic lupus erythematosus (SLE) is established and confirmed in Hispanic and European American families. Am J Hum Genet 2004; 74: 73–82
   Google Scholar
• Olson JM, Song Y, Dudek DM, et al. A genome screen of systemic lupus erythematosus using affected-relative-pair linkage analysis with covariates demonstrates genetic heterogeneity. Genes Immun 2002; 3(Suppl 1)S5–S12
   Google Scholar
• Ramos PS, Kelly JA, Gray-McGuire C, et al. Familial aggregation and linkage analysis of autoantibody traits in pedigrees multiplex for systemic lupus erythematosus. Genes Immun 2006; 7: 417–432
   PubMed Web of Science ®Google Scholar
• Rao S, Olson JM, Moser KL, et al. Linkage analysis of human systemic lupus erythematosus-related traits: A principal component approach. Arthritis Rheum 2001; 44: 2807–2818
   Google Scholar
• Shai R, Quismorio FP, Jr., Li L, et al. Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families. Hum Mol Genet 1999; 8: 639–644
   PubMed Web of Science ®Google Scholar
• Xing C, Sestak AL, Kelly JA, et al. Localization and replication of the systemic lupus erythematosus linkage signal at 4p16: Interaction with 2p11, 12q24 and 19q13 in European Americans. Hum Genet 2007; 120: 623–631
   Google Scholar
• Lander E, Kruglyak L. Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results. Nat Genet 1995; 11: 241–247
   PubMed Web of Science ®Google Scholar
• Forabosco P, Gorman JD, Cleveland C, et al. Meta-analysis of genome-wide linkage studies of systemic lupus erythematosus. Genes Immun 2006; 7: 609–614
   PubMed Web of Science ®Google Scholar
• Lee YH, Nath SK. Systemic lupus erythematosus susceptibility loci defined by genome scan meta-analysis. Hum Genet 2005; 118: 434–443
   PubMed Web of Science ®Google Scholar
• Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–1277
   PubMed Web of Science ®Google Scholar
• Kelly JA, Thompson K, Kilpatrick J, et al. Evidence for a susceptibility gene (SLEH1) on chromosome 11q14 for systemic lupus erythematosus (SLE) families with hemolytic anemia. Proc Natl Acad Sci USA 2002; 99: 11766–11771
   Google Scholar
• Nadeau JH. Modifier genes in mice and humans. Nat Rev Genet 2001; 2: 165–174
   PubMed Web of Science ®Google Scholar
• Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996; 273: 1516–1517
   PubMed Web of Science ®Google Scholar
• Becker KG. The common variants/multiple disease hypothesis of common complex genetic disorders. Med Hypotheses 2004; 62: 309–317
   PubMed Web of Science ®Google Scholar
• Salmon JE, Pricop L. Human receptors for immunoglobulin G: Key elements in the pathogenesis of rheumatic disease. Arthritis Rheum 2001; 44: 739–750
   PubMed Web of Science ®Google Scholar
• van der PW, van de Winkel JG. IgG receptor polymorphisms: Risk factors for disease. Immunogenetics 1998; 48: 222–232
   Google Scholar
• Salmon JE, Millard S, Schachter LA, et al. Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest 1996; 97: 1348–1354
   PubMed Web of Science ®Google Scholar
• Karassa FB, Trikalinos TA, Ioannidis JP. Role of the Fcgamma receptor IIa polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: A meta-analysis. Arthritis Rheum 2002; 46: 1563–1571
   PubMed Web of Science ®Google Scholar
• Wu J, Edberg JC, Redecha PB, et al. A novel polymorphism of Fc gammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J Clin Invest 1997; 100: 1059–1070
   PubMed Web of Science ®Google Scholar
• Karassa FB, Trikalinos TA, Ioannidis JP. The Fc gamma RIIIA-F158 allele is a risk factor for the development of lupus nephritis: A meta-analysis. Kidney Int 2003; 63: 1475–1482
   PubMed Web of Science ®Google Scholar
• Magnusson V, Johanneson B, Lima G, Odeberg J, arcon-Segovia D, arcon-Riquelme ME. Both risk alleles for FcgammaRIIA and FcgammaRIIIA are susceptibility factors for SLE: A unifying hypothesis. Genes Immun 2004; 5: 130–137
   PubMed Web of Science ®Google Scholar
• Kyogoku C, Dijstelbloem HM, Tsuchiya N, et al. Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: Contribution of FCGR2B to genetic susceptibility. Arthritis Rheum 2002; 46: 1242–1254
   PubMed Web of Science ®Google Scholar
• Su K, Wu J, Edberg JC, et al. A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcgammaRIIb alters receptor expression and associates with autoimmunity I. Regulatory FCGR2B polymorphisms and their association with systemic lupus erythematosus. J Immunol 2004; 172: 7186–7191
   PubMed Web of Science ®Google Scholar
• Redon R, Ishikawa S, Fitch KR, et al. Global variation in copy number in the human genome. Nature 2006; 444: 444–454
   PubMed Web of Science ®Google Scholar
• Aitman TJ, Dong R, Vyse TJ, et al. Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature 2006; 439: 851–855
   PubMed Web of Science ®Google Scholar
• Fanciulli M, Norsworthy PJ, Petretto E, et al. FCGR3B copy number variation is associated with susceptibility to systemic but not organ-specific autoimmunity Nat Genet 2007,39:721–723.
   Google Scholar
• Schifferli JA, Steiger G, Paccaud JP, Sjoholm AG, Hauptmann G. Difference in the biological properties of the two forms of the fourth component of human complement (C4). Clin Exp Immunol 1986; 63: 473–477
   PubMed Web of Science ®Google Scholar
• Pickering MC, Walport MJ. Links between complement abnormalities and systemic lupus erythematosus. Rheumatology (Oxford) 2000; 39: 133–141
   PubMed Web of Science ®Google Scholar
• Christiansen FT, Dawkins RL, Uko G, McCluskey J, Kay PH, Zilko PJ. Complement allotyping in SLE: Association with C4A null. Aust NZJ Med 1983; 13: 483–488
   Google Scholar
• Fielder AH, Walport MJ, Batchelor JR, et al. Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: Importance of null alleles of C4A and C4B in determining disease susceptibility. Br Med J (Clin Res Ed) 1983; 286: 425–428
   PubMed Web of Science ®Google Scholar
• Olsen ML, Goldstein R, Arnett FC, Duvic M, Pollack M, Reveille JD. C4A gene deletion and HLA associations in black Americans with systemic lupus erythematosus. Immunogenetics 1989; 30: 27–33
   PubMed Web of Science ®Google Scholar
• Yamada H, Watanabe A, Mimori A, et al. Lack of gene deletion for complement C4A deficiency in Japanese patients with systemic lupus erythematosus. J Rheumatol 1990; 17: 1054–1057
   Google Scholar
• Naves M, Hajeer AH, Teh LS, et al. Complement C4B null allele status confers risk for systemic lupus erythematosus in a Spanish population. Eur J Immunogenet 1998; 25: 317–320
   PubMedGoogle Scholar
• Yang Y, Chung EK, Zhou B, et al. The intricate role of complement component C4 in human systemic lupus erythematosus. Curr Dir Autoimmun 2004; 7: 98–132
   PubMedGoogle Scholar
• Johnson CA, Densen P, Hurford RK, Jr., Colten HR, Wetsel RA. Type I human complement C2 deficiency. A 28-base pair gene deletion causes skipping of exon 6 during RNA splicing. J Biol Chem 1992; 267: 9347–9353
   PubMed Web of Science ®Google Scholar
• Hartung K, Fontana A, Klar M, et al. Association of class I, II, and III MHC gene products with systemic lupus erythematosus. Results of a Central European multicenter study. Rheumatol Int 1989; 9: 13–18
   PubMed Web of Science ®Google Scholar
• Tsao BP. Update on human systemic lupus erythematosus genetics. Curr Opin Rheumatol 2004; 16: 513–521
   PubMed Web of Science ®Google Scholar
• Doherty DG, Ireland R, Demaine AG, et al. Major histocompatibility complex genes and susceptibility to systemic lupus erythematosus in southern Chinese. Arthritis Rheum 1992; 35: 641–646
   PubMedGoogle Scholar
• Howard PF, Hochberg MC, Bias WB, Arnett FC, Jr., McLean RH. Relationship between C4 null genes, HLA-D region antigens, and genetic susceptibility to systemic lupus erythematosus in Caucasian and black Americans. Am J Med 1986; 81: 187–193
   PubMed Web of Science ®Google Scholar
• Schur PH, Marcus-Bagley D, Awdeh Z, Yunis EJ, Alper CA. The effect of ethnicity on major histocompatibility complex complement allotypes and extended haplotypes in patients with systemic lupus erythematosus. Arthritis Rheum 1990; 33: 985–992
   PubMed Web of Science ®Google Scholar
• Graham RR, Ortmann WA, Langefeld CD, et al. Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. Am J Hum Genet 2002; 71: 543–553
   PubMed Web of Science ®Google Scholar
• de Bakker PI, McVean G, Sabeti PC, et al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet 2006; 38: 1166–1172
   PubMed Web of Science ®Google Scholar
• Walport MJ, Davies KA, Botto M. C1q and systemic lupus erythematosus. Immunobiology 1998; 199: 265–285
   PubMed Web of Science ®Google Scholar
• Turner MW, Hamvas RM. Mannose-binding lectin: Structure, function, genetics and disease associations. Rev Immunogenet 2000; 2: 305–322
   PubMedGoogle Scholar
• Garred P, Voss A, Madsen HO, Junker P. Association of mannose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematosus patients. Genes Immun 2001; 2: 442–450
   PubMed Web of Science ®Google Scholar
• Huang YF, Wang W, Han JY, et al. Increased frequency of the mannose-binding lectin LX haplotype in Chinese systemic lupus erythematosus patients. Eur J Immunogenet 2003; 30: 121–124
   PubMedGoogle Scholar
• Bharadwaj D, Stein MP, Volzer M, Mold C, Du Clos TW. The major receptor for C-reactive protein on leukocytes is fcgamma receptor II. J Exp Med 1999; 190: 585–590
   PubMed Web of Science ®Google Scholar
• Du Clos TW, Zlock LT, Rubin RL. Analysis of the binding of C-reactive protein to histones and chromatin. J Immunol 1988; 141: 4266–4270
   PubMed Web of Science ®Google Scholar
• Du Clos TW. C-reactive protein reacts with the U1 small nuclear ribonucleoprotein. J Immunol 1989; 143: 2553–2559
   PubMedGoogle Scholar
• Gershov D, Kim S, Brot N, Elkon KB. C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: Implications for systemic autoimmunity. J Exp Med 2000; 192: 1353–1364
   PubMed Web of Science ®Google Scholar
• Russell AI, Cunninghame Graham DS, Shepherd C, et al. Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet 2004; 13: 137–147
   PubMed Web of Science ®Google Scholar
• Ronnblom L, Alm GV. Systemic lupus erythematosus and the type I interferon system. Arthritis Res Ther 2003; 5: 68–75
   PubMed Web of Science ®Google Scholar
• Baechler EC, Batliwalla FM, Karypis G, et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci USA 2003; 100: 2610–2615
   PubMed Web of Science ®Google Scholar
• Bennett L, Palucka AK, Arce E, et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 2003; 197: 711–723
   PubMed Web of Science ®Google Scholar
• Theofilopoulos AN, Baccala R, Beutler B, Kono DH. Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol 2005; 23: 307–336
   PubMed Web of Science ®Google Scholar
• Sigurdsson S, Nordmark G, Goring HH, et al. Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet 2005; 76: 528–537
   PubMed Web of Science ®Google Scholar
• Graham RR, Kozyrev SV, Baechler EC, et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 2006; 38: 550–555
   PubMed Web of Science ®Google Scholar
• Cunninghame Graham DS, Manku H, Wagner S, et al. Association of IRF5 in UK SLE families identifies a variant involved in polyadenylation. Hum Mol Genet, 2007; 16: 579–591
   Google Scholar
• Graham RR, Kyogoku C, Sigurdsson S, et al. Three functional variants of interferon regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc Natl Acad Sci USA 2007; 104: 6758–6763
   PubMed Web of Science ®Google Scholar
• Cloutier JF, Veillette A. Association of inhibitory tyrosine protein kinase p50csk with protein tyrosine phosphatase PEP in T-cells and other hemopoietic cells. EMBO J 1996; 15: 4909–4918
   PubMed Web of Science ®Google Scholar
• Cloutier JF, Veillette A. Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J Exp Med 1999; 189: 111–121
   PubMed Web of Science ®Google Scholar
• Begovich AB, Carlton VE, Honigberg LA, et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004; 75: 330–337
   PubMed Web of Science ®Google Scholar
• Bottini N, Musumeci L, Alonso A, et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 2004; 36: 337–338
   PubMed Web of Science ®Google Scholar
• Vang T, Congia M, Macis MD, et al. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet 2005; 37: 1317–1319
   PubMed Web of Science ®Google Scholar
• Lee YH, Rho YH, Choi SJ, et al. The PTPN22 C1858T functional polymorphism and autoimmune diseases—a meta-analysis. Rheumatology (Oxford) 2007; 46: 49–56
   PubMed Web of Science ®Google Scholar
• Wu H, Cantor RM, Graham DS, et al. Association analysis of the R620W polymorphism of protein tyrosine phosphatase PTPN22 in systemic lupus erythematosus families: Increased T allele frequency in systemic lupus erythematosus patients with autoimmune thyroid disease. Arthritis Rheum 2005; 52: 2396–2402
   PubMedGoogle Scholar
• Agata Y, Kawasaki A, Nishimura H, et al. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int Immunol 1996; 8: 765–772
   PubMed Web of Science ®Google Scholar
• Nishimura H, Honjo T. PD-1: An inhibitory immunoreceptor involved in peripheral tolerance. Trends Immunol 2001; 22: 265–268
   PubMed Web of Science ®Google Scholar
• Nishimura H, Nose M, Hiai H, Minato N, Honjo T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 1999; 11: 141–151
   PubMed Web of Science ®Google Scholar
• Prokunina L, Castillejo-Lopez C, Oberg F, et al. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 2002; 32: 666–669
   PubMed Web of Science ®Google Scholar
• Prokunina L, Gunnarsson I, Sturfelt G, et al. The systemic lupus erythematosus-associated PDCD1 polymorphism PD1.3A in lupus nephritis. Arthritis Rheum 2004; 50: 327–328
   PubMed Web of Science ®Google Scholar
• Ferreiros-Vidal I, Gomez-Reino JJ, Barros F, et al. Association of PDCD1 with susceptibility to systemic lupus erythematosus: Evidence of population-specific effects. Arthritis Rheum 2004; 50: 2590–2597
   PubMed Web of Science ®Google Scholar
• Lin SC, Yen JH, Tsai JJ, et al. Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus. Arthritis Rheum 2004; 50: 770–775
   PubMed Web of Science ®Google Scholar
• Rudd CE, Schneider H. Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling. Nat Rev Immunol 2003; 3: 544–556
   PubMed Web of Science ®Google Scholar
• Quintero-Del-Rio AI, Kelly JA, Garriott CP, et al. SLEN2 (2q34–35) and SLEN1 (10q22.3) replication in systemic lupus erythematosus stratified by nephritis. Am J Hum Genet 2004; 75: 346–348
   Google Scholar
• Plenge RM, Padyukov L, Remmers EF, et al. Replication of putative candidate-gene associations with rheumatoid arthritis in >4000 samples from North America and Sweden: Association of susceptibility with PTPN22, CTLA4, and PADI4. Am J Hum Genet 2005; 77: 1044–1060
   PubMed Web of Science ®Google Scholar
• Ueda H, Howson JM, Esposito L, et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003; 423: 506–511
   PubMed Web of Science ®Google Scholar
• Barreto M, Santos E, Ferreira R, et al. Evidence for CTLA4 as a susceptibility gene for systemic lupus erythematosus. Eur J Hum Genet 2004; 12: 620–626
   PubMed Web of Science ®Google Scholar
• Lee YH, Harley JB, Nath SK. CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): A meta-analysis. Hum Genet 2005; 116: 361–367
   PubMed Web of Science ®Google Scholar
• Graham DS, Wong AK, McHugh NJ, Whittaker JC, Vyse TJ. Evidence for unique association signals in SLE at the CD28-CTLA4-ICOS locus in a family-based study. Hum Mol Genet 2006; 15: 3195–3205
   Google Scholar
• Chen Z, Liu Z, Zheng S, Liang Z. Expression of inducible co-stimulator in peripheral blood T lymphocytes in the patients with systemic lupus erythematosus. J Huazhong Univ Sci Technolog Med Sci 2005; 25: 357–359
   Google Scholar
• Barrat FJ, Meeker T, Gregorio J, et al. Nucleic acids of mammalian origin can act as endogenous ligands for toll-like receptors and may promote systemic lupus erythematosus. J Exp Med 2005; 202: 1131–1139
   PubMed Web of Science ®Google Scholar
• Krystosek A. Preferential sites of early DNA cleavage in apoptosis and the pathway of nuclear damage. Histochem Cell Biol 1999; 111: 265–276
   Google Scholar
• Lau CM, Broughton C, Tabor AS, et al. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/toll-like receptor 7 engagement. J Exp Med 2005; 202: 1171–1177
   PubMed Web of Science ®Google Scholar
• Viglianti GA, Lau CM, Hanley TM, Miko BA, Shlomchik MJ, Marshak-Rothstein A. Activation of autoreactive B cells by CpG dsDNA. Immunity 2003; 19: 837–847
   PubMed Web of Science ®Google Scholar
• Christensen SR, Shupe J, Nickerson K, Kashgarian M, Flavell RA, Shlomchik MJ. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 2006; 25: 417–428
   PubMed Web of Science ®Google Scholar
• De Jager PL, Richardson A, Vyse TJ, Rioux JD. Genetic variation in toll-like receptor 9 and susceptibility to systemic lupus erythematosus. Arthritis Rheum 2006; 54: 1279–1282
   PubMed Web of Science ®Google Scholar
• Hur JW, Shin HD, Park BL, Kim LH, Kim SY, Bae SC. Association study of Toll-like receptor 9 gene polymorphism in Korean patients with systemic lupus erythematosus. Tissue Antigens 2005; 65: 266–270
   PubMed Web of Science ®Google Scholar
• Ng MW, Lau CS, Chan TM, Wong WH, Lau YL. Polymorphisms of the toll-like receptor 9 (TLR9) gene with systemic lupus erythematosus in Chinese. Rheumatology (Oxford) 2005; 44: 1456–1457
   PubMed Web of Science ®Google Scholar
• Pisitkun P, Deane JA, Difilippantonio MJ, Tarasenko T, Satterthwaite AB, Bolland S. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 2006; 312: 1669–1672
   PubMed Web of Science ®Google Scholar
• Chan AY, Westcott JM, Mooney JM, Wakeland EK, Schatzle JD. The role of SAP and the SLAM family in autoimmunity. Curr Opin Immunol 2006; 18: 656–664
   PubMed Web of Science ®Google Scholar
• Morel L, Blenman KR, Croker BP, Wakeland EK. The major murine systemic lupus erythematosus susceptibility locus, Sle1, is a cluster of functionally related genes. Proc Natl Acad Sci USA 2001; 98: 1787–1792
   PubMed Web of Science ®Google Scholar
• Wandstrat AE, Nguyen C, Limaye N, et al. Association of extensive polymorphisms in the SLAM/CD2 gene cluster with murine lupus. Immunity 2004; 21: 769–780
   PubMed Web of Science ®Google Scholar
• Kumar KR, Li L, Yan M, et al. Regulation of B cell tolerance by the lupus susceptibility gene Ly108. Science 2006; 312: 1665–1669
   PubMed Web of Science ®Google Scholar
• Wandstrat A, Wakeland E. The genetics of complex autoimmune diseases: Non-MHC susceptibility genes. Nat Immunol 2001; 2: 802–809
   PubMedGoogle Scholar
• Velaga MR, Wilson V, Jennings CE, et al. The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease. J Clin Endocrinol Metab 2004; 89: 5862–5865
   PubMed Web of Science ®Google Scholar
• Viken MK, Amundsen SS, Kvien TK, et al. Association analysis of the 1858C>T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases. Genes Immun 2005; 6: 271–273
   PubMed Web of Science ®Google Scholar
• Tsao BP, Cantor RM, Kalunian KC, et al. Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J Clin Invest 1997; 99: 725–731
   PubMed Web of Science ®Google Scholar